News Senior FDA resignations gut drug advertising function Two senior officials at the FDA's drug promotion office have resigned, leading to speculation that a clampdown on some advertising may be on the way.
News EVERSANA adds AI to medical, legal and regulatory reviews A new AI-powered solution from EVERSANA aims to take the pain out of medical, legal and regulatory (MLR) reviews.
Sales & Marketing Harnessing zero‑party data: Transforming pharma advertising ... Integrating zero-party data into ads, pharma and healthcare brands can revolutionise how they engage with patients
News Lilly uses Oscars ad to warn about 'untested' GLP-1s Eli Lilly has used an Oscars ad to urge people not to use unapproved and untested weight-loss medicines in a swipe at the compounding sector.
Sales & Marketing 5 takeaways from Super Bowl LIX: What health and pharma can ... Super Bowl advertising has always been about pushing boundaries, capturing attention, and setting new creative standards. But this year, the risk-taking was noticeably dialled down.
News Pharma group slams Hims & Hers over Super Bowl GLP-1 ad Partnership for Safe Medicines claims the Hims & Hers ad for compounded weight-loss drug semaglutide, due to run during the Super Bowl, is "reckless."
R&D Modelling biologics: Challenges and opportunities, with Dr D... From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.